Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial.

Congenital heart defect Exercise therapies Patient education Physical activity Physical fitness Quality of life

Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
02 Mar 2024
Historique:
received: 06 08 2023
revised: 17 01 2024
accepted: 30 01 2024
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 2 3 2024
Statut: aheadofprint

Résumé

Cardiopulmonary fitness in congenital heart disease (CHD) decreases faster than in the general population resulting in impaired health-related quality of life (HRQoL). As the standard of care seems insufficient to encourage and maintain fitness, an early hybrid cardiac rehabilitation programme could improve HRQoL in CHD. The QUALIREHAB multicentre, randomized, controlled trial evaluated and implemented a 12-week centre- and home-based hybrid cardiac rehabilitation programme, including multidisciplinary care and physical activity sessions. Adolescent and young adult CHD patients with impaired cardiopulmonary fitness were randomly assigned to either the intervention (i.e. cardiac rehabilitation) or the standard of care. The primary outcome was the change in HRQoL from baseline to 12-month follow-up in an intention-to-treat analysis. The secondary outcomes were the change in cardiovascular parameters, cardiopulmonary fitness, and mental health. The expected number of 142 patients was enroled in the study (mean age 17.4 ± 3.4 years, 52% female). Patients assigned to the intervention had a significant positive change in HRQoL total score [mean difference 3.8; 95% confidence interval (CI) 0.2; 7.3; P = .038; effect size 0.34], body mass index [mean difference -0.7 kg/m2 (95% CI -1.3; -0.1); P = .022; effect size 0.41], level of physical activity [mean difference 2.5 (95% CI 0.1; 5); P = .044; effect size 0.39], and disease knowledge [mean difference 2.7 (95% CI 0.8; 4.6); P = .007; effect size 0.51]. The per-protocol analysis confirmed these results with a higher magnitude of differences. Acceptability, safety, and short-time effect of the intervention were good to excellent. This early hybrid cardiac rehabilitation programme improved HRQoL, body mass index, physical activity, and disease knowledge, in youth with CHD, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Cardiopulmonary fitness in congenital heart disease (CHD) decreases faster than in the general population resulting in impaired health-related quality of life (HRQoL). As the standard of care seems insufficient to encourage and maintain fitness, an early hybrid cardiac rehabilitation programme could improve HRQoL in CHD.
METHODS METHODS
The QUALIREHAB multicentre, randomized, controlled trial evaluated and implemented a 12-week centre- and home-based hybrid cardiac rehabilitation programme, including multidisciplinary care and physical activity sessions. Adolescent and young adult CHD patients with impaired cardiopulmonary fitness were randomly assigned to either the intervention (i.e. cardiac rehabilitation) or the standard of care. The primary outcome was the change in HRQoL from baseline to 12-month follow-up in an intention-to-treat analysis. The secondary outcomes were the change in cardiovascular parameters, cardiopulmonary fitness, and mental health.
RESULTS RESULTS
The expected number of 142 patients was enroled in the study (mean age 17.4 ± 3.4 years, 52% female). Patients assigned to the intervention had a significant positive change in HRQoL total score [mean difference 3.8; 95% confidence interval (CI) 0.2; 7.3; P = .038; effect size 0.34], body mass index [mean difference -0.7 kg/m2 (95% CI -1.3; -0.1); P = .022; effect size 0.41], level of physical activity [mean difference 2.5 (95% CI 0.1; 5); P = .044; effect size 0.39], and disease knowledge [mean difference 2.7 (95% CI 0.8; 4.6); P = .007; effect size 0.51]. The per-protocol analysis confirmed these results with a higher magnitude of differences. Acceptability, safety, and short-time effect of the intervention were good to excellent.
CONCLUSIONS CONCLUSIONS
This early hybrid cardiac rehabilitation programme improved HRQoL, body mass index, physical activity, and disease knowledge, in youth with CHD, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease.

Identifiants

pubmed: 38430485
pii: 7617843
doi: 10.1093/eurheartj/ehae085
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : French Ministry of Health
Organisme : French Society of Cardiology
Organisme : French Federation of Cardiology
Organisme : Saint-Pierre Foundation
Organisme : APARD healthcare provider

Investigateurs

Pascal Amedro (P)
Arthur Gavotto (A)
Helena Huguet (H)
Luc Souilla (L)
Anne-Cecile Huby (AC)
Johanna Calderon (J)
Stefan Matecki (S)
Anne Cadene (A)
Gregoire De La Villeon (G)
Marie Vincenti (M)
Oscar Werner (O)
D'Arcy Vandenberghe (D)
Charlene Bredy (C)
Kathleen Lavastre (K)
Hamouda Abassi (H)
Sarah Cohen (S)
Sebastien Hascoet (S)
Claire Dauphin (C)
Aurelie Chalard (A)
Yves Dulac (Y)
Nathalie Souletie (N)
Philippe Acar (P)
Helene Bouvaist (H)
Stephanie Douchin (S)
Matthias Lachaud (M)
Caroline Ovaert (C)
Camille Soulatges (C)
Nicolas Combes (N)
Jean-Benoit Thambo (JB)
Xavier Iriart (X)
Emilie Testet (E)
Fanny Bajolle (F)
Antoine Legendre (A)
Damien Bonnet (D)
Helene Ansquer (H)
Jean-Guillaume Delpey (JG)
Laurence Cohen (L)
Victor Pommier (V)
Remi Vincent (R)
Frederique Sidney-Hetmaniak (F)
Laurent Poirette (L)
Sonia Corone (S)
Cecile Rocca (C)
Marianne Noirclerc (M)
Oxana-Anca Neagu (OA)
Hervé Ngayap-Nemkam (H)
Isaam Kammache (I)
Clara Bourgarde (C)
Jean-Marie Chevalier (JM)
Christelle Pons (C)
Marie-Christine Picot (MC)
Sophie Guillaumont (S)

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Pascal Amedro (P)

Department of Fetal, Pediatric and Adult Congenital Cardiology, M3C National CHD Reference Centre, Bordeaux University Hospital, Haut-Leveque Hospital, Avenue de Magellan, 33604 Pessac Cedex, France.
IHU Liryc, INSERM 1045, University of Bordeaux, Avenue du Haut-Leveque, 33600 Pessac, France.

Arthur Gavotto (A)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.

Helena Huguet (H)

Epidemiology and Clinical Research Department, University Hospital, University of Montpellier, Montpellier, France.

Luc Souilla (L)

PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.

Anne-Cecile Huby (AC)

Department of Fetal, Pediatric and Adult Congenital Cardiology, M3C National CHD Reference Centre, Bordeaux University Hospital, Haut-Leveque Hospital, Avenue de Magellan, 33604 Pessac Cedex, France.
IHU Liryc, INSERM 1045, University of Bordeaux, Avenue du Haut-Leveque, 33600 Pessac, France.

Stefan Matecki (S)

PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.

Anne Cadene (A)

Epidemiology and Clinical Research Department, University Hospital, University of Montpellier, Montpellier, France.

Gregoire De La Villeon (G)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Pediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France.

Marie Vincenti (M)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.
Pediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France.

Oscar Werner (O)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Pediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France.

Charlene Bredy (C)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Fontfroide Cardiac Rehabilitation Center, 1800 rue de Saint-Priest, 34097 Montpellier, France.

Kathleen Lavastre (K)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.

Hamouda Abassi (H)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.

Sarah Cohen (S)

Pediatric and Congenital Cardiology Department, M3C National Reference CHD Centre, Marie-Lannelongue Hospital, Le Plessis-Robinson, France.

Sebastien Hascoet (S)

Pediatric and Congenital Cardiology Department, M3C National Reference CHD Centre, Marie-Lannelongue Hospital, Le Plessis-Robinson, France.

Claire Dauphin (C)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Aurelie Chalard (A)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Yves Dulac (Y)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Toulouse University Hospital, Toulouse, France.

Nathalie Souletie (N)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Toulouse University Hospital, Toulouse, France.

Helene Bouvaist (H)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Grenoble University Hospital, Grenoble, France.

Stephanie Douchin (S)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Grenoble University Hospital, Grenoble, France.

Matthias Lachaud (M)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Grenoble University Hospital, Grenoble, France.

Caroline Ovaert (C)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, APHM La Timone Hospital, Marseille, France.

Camille Soulatges (C)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, APHM La Timone Hospital, Marseille, France.

Nicolas Combes (N)

Pediatric and Congenital Cardiology Department, Pasteur Clinic, Toulouse, France.

Jean-Benoit Thambo (JB)

Department of Fetal, Pediatric and Adult Congenital Cardiology, M3C National CHD Reference Centre, Bordeaux University Hospital, Haut-Leveque Hospital, Avenue de Magellan, 33604 Pessac Cedex, France.
IHU Liryc, INSERM 1045, University of Bordeaux, Avenue du Haut-Leveque, 33600 Pessac, France.

Xavier Iriart (X)

Department of Fetal, Pediatric and Adult Congenital Cardiology, M3C National CHD Reference Centre, Bordeaux University Hospital, Haut-Leveque Hospital, Avenue de Magellan, 33604 Pessac Cedex, France.

Fanny Bajolle (F)

Pediatric and Congenital Cardiology Department, M3C National Reference CHD Centre, APHP Necker Hospital, Paris, France.

Damien Bonnet (D)

Pediatric and Congenital Cardiology Department, M3C National Reference CHD Centre, APHP Necker Hospital, Paris, France.

Helene Ansquer (H)

Pediatric and Congenital Cardiology Department, Brest University Hospital, Brest, France.

Jean-Guillaume Delpey (JG)

Pediatric and Congenital Cardiology Department, Brest University Hospital, Brest, France.

Laurence Cohen (L)

Fetal, Pediatric and Congenital Private Practice, 8 rue du Conseil de l'Europe, 91300 Massy, France.

Marie-Christine Picot (MC)

Epidemiology and Clinical Research Department, University Hospital, University of Montpellier, Montpellier, France.
Clinical Investigation Centre, INSERM-CIC 1411, University of Montpellier, Montpellier, France.

Sophie Guillaumont (S)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Pediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France.

Classifications MeSH